Skip to content
HeyJared

Lisa Kuhns

Reporter

Indexed articles, last 90 days
6
Latest publication
Sep 9, 2026
Outlet visibility, for Oncology Nurse Advisor
Top 5M sites
Earliest in this view
Jul 22, 2026

Latest articles

  1. Article · Sep 9, 2026 · Lisa Kuhns, PhD | Publish Date September 9, 2026

    Longitudinal Melanocytic Lesion Patterns May Guide Melanoma Risk Stratification (opens the original)

    Excerpt · English

    Read excerpt

    Persistent or increasing peripheral globules, faster lesion growth, increasing pigmentation, and a personal history of melanoma are associated with adverse outcomes in melanocytic lesions, according to results of a study published in the Journal of the American Academy of Dermatology. Researchers conducted a single-center ambispective study that included a retrospective phase (1998-2024) and a prospective phase (2024-2025) to identify longitudinal changes in dermoscopic patterns of melanocytic n

  2. Article · Sep 9, 2026 · Lisa Kuhns, PhD | Publish Date September 9, 2026

    Longitudinal Melanocytic Lesion Patterns May Guide Melanoma Risk Stratification - Oncology Nurse Advisor (opens the original)

    Excerpt · English

    Read excerpt

    Persistent or increasing peripheral globules, faster lesion growth, increasing pigmentation, and a personal history of melanoma are associated with adverse outcomes in melanocytic lesions, according to results of a study published in the Journal of the American Academy of Dermatology. Researchers conducted a single-center ambispective study that included a retrospective phase (1998-2024) and a prospective phase (2024-2025) to identify longitudinal changes in dermoscopic patterns of melanocytic n

  3. Article · Sep 3, 2026 · Lisa Kuhns, PhD | Publish Date September 3, 2026

    Eye-Preserving Therapy Achieves Favorable Outcomes in Early Retinoblastoma (opens the original)

    Excerpt · Neutral tone · English

    Read excerpt

    In patients with early cT3c retinoblastoma (neovascular glaucoma without buphthalmos), primary eye-preserving therapy achieves meaningful globe and vision salvage without compromising survival or increasing high-risk pathological features, according to results of a study published in Ophthalmology. Researchers conducted a retrospective single-center cohort study including 132 patients (133 eyes) with early cT3c retinoblastoma treated between May 2014 and October 2024. Patients underwent either p

  4. Article · Sep 2, 2026 · Lisa Kuhns, PhD | Publish Date September 2, 2026

    Higher Ocular Radiation Doses Linked to Vision Loss After Plaque Therapy - Oncology Nurse Advisor (opens the original)

    Excerpt · English

    Read excerpt

    Among patients with posterior uveal melanoma (PUM) treated with plaque radiotherapy, higher radiation doses to the optic disc and foveola are associated with greater long-term risk of ≥15-letter visual acuity loss, according to results of a study published in Retina. Researchers conducted a retrospective study of 4000 eyes with PUM involving the choroid and/or ciliary body that were treated with a single course of plaque radiotherapy at Wills Eye Hospital between 1976 and 2008, without prophylac

  5. Article · Aug 19, 2026 · Lisa Kuhns, PhD | Publish Date August 19, 2026

    Vitreoretinal Lymphoma Scoring Tool Accurately Differentiates Disease From Uveitis (opens the original)

    Excerpt · Positive tone · English

    Read excerpt

    The Interleukin Score for IntraOcular Lymphoma Diagnosis (ISOLD) demonstrates excellent diagnostic accuracy for vitreoretinal lymphoma (VRL), particularly when used with aqueous humor sampling, and provides a valuable adjunct to cytology and molecular testing in routine clinical practice, according to results of a study published in the American Journal of Ophthalmology. Researchers conducted a retrospective diagnostic study that evaluated the performance of the ISOLD score in patients undergoin

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 5M sites

For Oncology Nurse Advisor, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Lisa Kuhns